Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings

      Chronic wounds are a major healthcare problem costing the United States billions of dollars a year. The American Academy of Dermatology has underscored the significance of wound care in dermatological practice. It is critical for all dermatologists to understand the elements of diagnosis and therapy. We emphasize major aspects of diagnosis and present a simple classification of wound dressings with guidelines for usage and relative cost data.

      Learning objective

      After completing this learning activity, participants should be able to diagnose common types of chronic wounds, formulate a therapeutic plan, and describe the major classes of topical therapies and dressings for the chronic wound.

      Abbreviations:

      ABI (ankle-brachial index), CMC (carboxymethylcellulose), CRP (C-reactive protein), ESR (erythrocyte sedimentation rate), MRI (magnetic resonance imaging), MRSA (methicillin-resistant Staphylococcus aureus), PG (pyoderma gangrenosum), rhPDGF (recombinant human platelet-derived growth factor), TBI (toe-brachial index), TNP (topical negative pressure), VAC (vacuum-assisted closure), VEGF (vascular endothelial growth factor), VRE (vancomycin-resistant enterococci)
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fowler E.
        Chronic wounds: an overview.
        in: Krasner D. Chronic wound care: a clinical source book for healthcare professionals. Health Management Publications, Inc, King of Prussia, PA1990: 12-18
        • Singh A.
        • Halder S.
        • Menon G.R.
        • Chumber S.
        • Misra M.C.
        • Sharma L.K.
        • et al.
        Meta-analysis of randomized controlled trials on hydrocolloid occlusive dressing versus conventional gauze dressing in the healing of chronic wounds.
        Asian J Surg. 2004; 27: 326-332
        • Rees R.S.
        • Hirshberg J.A.
        Wound care centers: costs, care, and strategies.
        Adv Wound Care. 1999; 12: 4-7
        • Callam M.
        Prevalence of chronic leg ulceration and severe chronic venous disease in Western countries.
        Phlebology. 1992; 7: S6-S12
        • Nelzen O.
        • Bergqvist D.
        • Linghagen A.
        The prevalence of chronic lower-limb ulceration has been underestimated: results of a validated population questionnaire.
        Br J Surg. 1996; 83: 255-258
        • Bergan J.J.
        • Schmid-Schönbein G.W.
        • Coleridge Smith P.D.
        • Nicolaides A.N.
        • Boisseau M.R.
        • Eklof B.
        Mechanisms of disease: chronic venous disease.
        N Engl J Med. 2006; 355: 488-498
        • Walmsley S.
        Advances in wound management: executive summary.
        in: Clinica reports. PJB Publications, Ltd, London2002
        • Goldman R.
        Growth factors and chronic wound healing: past, present, and future.
        Adv Skin Wound Care. 2004; 17: 24-35
        • Baum C.L.
        • Arpey C.J.
        Normal cutaneous wound healing: clinical correlation with cellular and molecular events.
        Dermatol Surg. 2005; 31: 674-686
        • Singer A.J.
        • Clark R.A.
        Cutaneous wound healing.
        N Engl J Med. 1999; 341: 738-746
        • Ehrlich H.P.
        • Hunt T.K.
        Effects of cortisone and vitamin A on wound healing.
        Ann Surg. 1968; 167: 324-328
        • Gupta A.
        • Jain G.K.
        • Raghubir R.
        A time course study for the development of an immunocompromised wound model, using hydrocortisone.
        J Pharmacol Toxicol Methods. 1999; 41: 183-187
        • Sibbald R.G.
        • Cameron J.
        Dermatological aspects of wound care.
        in: Krasner D.L. Rodeheaver G.T. Sibbald R.G. Chronic wound care: a clinical source book for healthcare professionals. 3rd ed. Health Management Publications, Wayne, PA2001: 273-285
        • Belsito D.V.
        • Fowler J.F.
        • Sasseville D.
        • Marks J.G.
        • De Leo V.A.
        • Storrs F.J.
        Delayed-type hypersensitivity to fragrance materials in a select North American population.
        Dermatitis. 2006; 17: 23-28
        • Zaki I.
        • Shall L.
        • Dalziel K.L.
        Bacitracin: a significant sensitizer in leg ulcer patients?.
        Contact Dermatitis. 1994; 31: 92-94
        • Goh C.L.
        Contact sensitivity to topical antimicrobials (I). Epidemiology in Singapore.
        Contact Dermatitis. 1989; 21: 46-48
        • Siegel D.M.
        Contact sensitivity and recalcitrant wounds.
        Ostomy Wound Manage. 2000; 46: S65-S74
        • Branemark P.I.
        • Ekholm R.
        Tissue injury caused by wound disinfectants.
        J Bone Joint Surg Am. 1967; 49: 48-62
        • Oberg M.S.
        • Lindsey D.
        Do not put hydrogen peroxide or povidone iodine into wounds!.
        Am J Dis Child. 1987; 141: 27-28
        • Damour O.
        • Hua S.Z.
        • Lasne F.
        • Villain M.
        • Rousselle P.
        • Collombel C.
        Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes.
        Burns. 1992; 18: 479-485
        • Balin A.K.
        • Pratt L.
        Dilute povidone-iodine solutions inhibit human skin fibroblast growth.
        Dermatol Surg. 2002; 28: 210-214
        • Lin E.
        • Kotani J.G.
        • Lowry S.F.
        Nutritional modulation of immunity and the inflammatory response.
        Nutrition. 1998; 14: 545-550
        • Thomas D.R.
        Improving outcome of pressure ulcers with nutritional interventions: a review of the evidence.
        Nutrition. 2001; 17: 121-125
        • Mathus-Vliegen E.M.
        Old age, malnutrition, and pressure sores: an ill-fated alliance.
        J Gerontol A Biol Sci Med Sci. 2004; 59: 355-360
        • Freiman A.
        • Bird G.
        • Metelitsa A.I.
        • Barankin B.
        • Lauzon G.J.
        Cutaneous effects of smoking.
        J Cutan Med Surg. 2004; 8: 415-423
        • Benveniste K.
        • Thut P.
        The effect of chronic alcoholism on wound healing.
        Proc Soc Exp Biol Med. 1981; 166: 568-575
        • Nelzen O.
        • Bergqvist D.
        • Lindhagen A.
        Venous and non-venous leg ulcers: clinical history and appearance in a population study.
        Br J Surg. 1994; 81: 182-187
        • Valencia I.C.
        • Falabella A.
        • Kirsner R.S.
        • Eaglstein W.H.
        Chronic venous insufficiency and venous leg ulceration.
        J Am Acad Dermatol. 2001; 44: 401-421
        • Grey J.E.
        • Harding K.G.
        • Enoch S.
        Venous and arterial leg ulcers.
        BMJ. 2006; 332: 347-350
        • Callam M.J.
        • Harper D.R.
        • Dale J.J.
        • Ruckley C.V.
        Arterial disease in chronic leg ulceration: an underestimated hazard? Lothian and Forth Valley leg ulcer study.
        Br Med J (Clin Res Ed). 1987; 294: 929-931
        • Falanga V.
        Wound healing and its impairment in the diabetic foot.
        Lancet. 2005; 366: 1736-1743
        • Andersson E.
        • Hansson C.
        • Swanbeck G.
        Leg and foot ulcer prevalence and investigation of the peripheral arterial and venous circulation in a randomised elderly population. An epidemiological survey and clinical investigation.
        Acta Derm Venereol. 1993; 73: 57-61
        • Singh N.
        • Armstrong D.G.
        • Lipsky B.A.
        Preventing foot ulcers in patients with diabetes.
        JAMA. 2005; 293: 217-228
        • Brem H.
        • Sheehan P.
        • Rosenberg H.J.
        • Schneider J.S.
        • Boulton A.J.
        Evidence-based protocol for diabetic foot ulcers.
        Plast Reconstr Surg. 2006; 117: S193-S209
        • Bergin S.M.
        • Wraight P.
        Silver based wound dressings and topical agents for treating diabetic foot ulcers.
        Cochrane Database Syst Rev. 2006; 1 (CD005082)
        • Calvet H.M.
        • Yoshikawa T.T.
        Infections in diabetes.
        Infect Dis Clin North Am. 2001; 15: 407-421
        • Zykova S.N.
        • Jenssen T.G.
        • Berdal M.
        • Olsen R.
        • Myklebust R.
        • Seljelid R.
        Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice.
        Diabetes. 2000; 49: 1451-1458
        • Naghibi M.
        • Smith R.P.
        • Baltch A.L.
        • Gates S.A.
        • Wu D.H.
        • Hammer M.C.
        • et al.
        The effect of diabetes mellitus on chemotactic and bactericidal activity of human polymorphonuclear leukocytes.
        Diabetes Res Clin Pract. 1987; 4: 27-35
        • Margolis D.J.
        • Allen-Taylor L.
        • Hoffstad O.
        • Berlin J.A.
        Diabetic neuropathic foot ulcers and amputation.
        Wound Repair Regen. 2005; 13: 230-236
        • Lipsky B.A.
        Osteomyelitis of the foot in diabetic patients.
        Clin Infect Dis. 1997; 25: 1318-1326
        • Bansal C.
        • Scott R.
        • Stewart D.
        • Cockerell C.J.
        Decubitus ulcers: a review of the literature.
        Int J Dermatol. 2005; 44: 805-810
        • Gottrup F.
        • Karlsmark T.
        Leg ulcers: uncommon presentations.
        Clin Dermatol. 2005; 23: 601-611
        • Su W.P.
        • Davis M.D.
        • Weenig R.H.
        • Powell F.C.
        • Perry H.O.
        Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria.
        Int J Dermatol. 2004; 43: 790-800
        • Crowson A.N.
        • Mihm M.C.
        • Magro C.
        Pyoderma gangrenosum: a review.
        J Cutan Pathol. 2003; 30: 97-107
        • Powell F.C.
        • O'Kane M.
        Management of pyoderma gangrenosum.
        Dermatol Clin. 2002; 20: 347-355
        • Prystowsky J.H.
        • Kahn S.N.
        • Lazarus G.S.
        Present status of pyoderma gangrenosum: review of 21 cases.
        Arch Dermatol. 1989; 125: 57-64
        • Matis W.L.
        • Ellis C.N.
        • Griffiths C.E.
        • Lazarus G.S.
        Treatment of pyoderma gangrenosum with cyclosporine.
        Arch Dermatol. 1992; 128: 1060-1064
        • Ovington L.G.
        The evolution of wound management: ancient origins and advances of the past 20 years.
        Home Healthc Nurse. 2002; 20: 652-656
        • Rovee D.T.
        Evolution of wound dressings and their effects on the healing process.
        Clin Mater. 1991; 8: 183-188
        • Winter G.D.
        Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig.
        Nature. 1962; 193: 293-294
        • Winter G.D.
        Epidermal regeneration studied in the domestic pig.
        in: Rovee D. Maibach H. Epidermal wound healing. Year Book Medical Publishers, Chicago1972: 71-112
        • Ovington L.G.
        Wound dressings: their evolution and use.
        in: Falanga V. Cutaneous wound healing. Martin Dunitz, Ltd, London2001: 221-232
        • Alvarez O.M.
        • Mertz P.M.
        • Eaglstein W.H.
        The effect of occlusive dressings on collagen synthesis and re-epithelialization in superficial wounds.
        J Surg Res. 1983; 35: 142-148
        • Varghese M.C.
        • Balin A.K.
        • Carter D.M.
        • Caldwell D.
        Local environment of chronic wounds under synthetic dressings.
        Arch Dermatol. 1986; 122: 52-57
        • Knighton D.R.
        • Silver I.A.
        • Hunt T.K.
        Regulation of wound-healing angiogenesis—effect of oxygen gradients and inspired oxygen concentration.
        Surgery. 1981; 90: 262-270
        • Barnett A.
        • Berkowitz R.L.
        • Mills R.
        • Vistnes L.M.
        Comparison of synthetic adhesive moisture vapor permeable and fine mesh gauze dressings for split-thickness skin graft donor sites.
        Am J Surg. 1983; 145: 379-381
        • Eaglstein W.H.
        • Mertz P.M.
        • Falanga V.
        Occlusive dressings.
        Am Fam Physician. 1987; 35: 211-216
        • Nemeth A.J.
        • Eaglstein W.H.
        • Taylor J.R.
        • Peerson L.J.
        • Falanga V.
        Faster healing and less pain in skin biopsy sites treated with an occlusive dressing.
        Arch Dermatol. 1991; 127: 1679-1683
        • Field F.K.
        • Kerstein M.D.
        Overview of wound healing in a moist environment.
        Am J Surg. 1994; 167: S2-S6
        • Hutchinson J.J.
        • Lawrence J.C.
        Wound infection under occlusive dressings.
        J Hosp Infect. 1991; 17: 83-94
        • Mertz P.M.
        • Marshall D.A.
        • Eaglstein W.H.
        Occlusive wound dressings to prevent bacterial invasion and wound infection.
        J Am Acad Dermatol. 1985; 12: 662-668
        • Colebrook L.
        • Hood A.M.
        Infection through soaked dressings.
        Lancet. 1948; 252: 682-683
        • Cutting K.F.
        • White R.J.
        Avoidance and management of peri-wound maceration of the skin.
        Prof Nurse. 2002; 18: 33-36
        • Phillips T.J.
        • al-Amoudi H.O.
        • Leverkus M.
        • Park H.Y.
        Effect of chronic wound fluid on fibroblasts.
        J Wound Care. 1998; 7: 527-532
        • Seah C.C.
        • Phillips T.J.
        • Howard C.E.
        • Panova I.P.
        • Hayes C.M.
        • Asandra A.S.
        • et al.
        Chronic wound fluid suppresses proliferation of dermal fibroblasts through a Ras-mediated signaling pathway.
        J Invest Dermatol. 2005; 124: 466-474
        • Trengove N.J.
        • Stacey M.C.
        • MacAuley S.
        • Bennett N.
        • Gibson J.
        • Burslem F.
        • et al.
        Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
        Wound Repair Regen. 1999; 7: 442-452
        • Barrick B.
        • Campbell E.J.
        • Owen C.A.
        Leukocyte proteinases in wound healing: roles in physiologic and pathologic processes.
        Wound Repair Regen. 1999; 7: 410-422
        • Medina A.
        • Scott P.G.
        • Ghahary A.
        • Tredget E.E.
        Pathophysiology of chronic nonhealing wounds.
        J Burn Care Rehabil. 2005; 26: 306-319
        • Kingsley A.
        The wound infection continuum and its application to clinical practice.
        Ostomy Wound Manage. 2003; 49: S1-S7
        • Levenson S.M.
        • Kan-Gruber D.
        • Gruber C.
        • Molnar J.
        • Seifter E.
        Wound healing accelerated by Staphylococcus aureus.
        Arch Surg. 1983; 118: 310-320
        • Laato M.
        • Niinikoski J.
        • Lundberg C.
        • Gerdin B.
        Inflammatory reaction and blood flow in experimental wounds inoculated with Staphylococcus aureus.
        Eur Surg Res. 1988; 20: 33-38
        • Robson M.C.
        • Stenberg B.D.
        • Heggers J.P.
        Wound healing alterations caused by infection.
        Clin Plast Surg. 1990; 17: 485-492
        • Trengove N.J.
        • Stacey M.C.
        • McGechie D.F.
        • Mata S.
        Qualitative bacteriology and leg ulcer healing.
        J Wound Care. 1996; 5: 277-280
        • Bowler P.G.
        • Duerden B.I.
        • Armstrong D.G.
        Wound microbiology and associated approaches to wound management.
        Clin Microbiol Rev. 2001; 14: 244-269
        • Bowler P.G.
        • Davies B.J.
        The microbiology of infected and noninfected leg ulcers.
        Int J Dermatol. 1999; 38: 573-578
        • Steed D.L.
        Debridement.
        Am J Surg. 2004; 187: S71-S74
        • Williams D.
        • Enoch S.
        • Miller D.
        • Harris K.
        • Price P.
        • Harding K.G.
        Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study.
        Wound Rep Reg. 2005; 13: 131-137
        • Steed D.L.
        • Donohoe D.
        • Webster M.W.
        • Lindsley L.
        Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group.
        J Am Coll Surg. 1996; 183: 61-64
        • Bale S.
        A guide to wound debridement.
        J Wound Care. 1997; 6: 179-182
        • Hess C.T.
        Wound care.
        5th ed. Lippincott Williams and Wilkins, Baltimore, MD2005
        • Romanelli M.
        The use of systemic and topical agents for wound healing.
        in: Falanga V. Cutaneous wound healing. Martin Dunitz Ltd, London2001: 357-368
        • Alvarez O.M.
        • Fernandez-Obregon A.
        • Rogers R.S.
        • Bergamo L.
        • Masso J.
        • Black M.
        A prospective, randomized, comparative study of collagenase and papain-urea for pressure ulcer debridement.
        Wounds. 2002; 14: 293-301
        • Hebda P.A.
        • Lo C.Y.
        The effects of active ingredients of standard debriding agents—papain and collagenase—on digestion of native and denatured collagenous substrates, fibrin, and elastin.
        Wounds. 2001; 13: 190-194
        • Hebda P.A.
        • Flynn K.J.
        • Dohar J.E.
        Evaluation of the efficacy of enzymatic debriding agents for removal of necrotic tissue and promotion of healing in porcine skin wounds.
        Wounds. 1998; 10: 83-96
        • Konig M.
        • Vanscheidt W.
        • Augustin M.
        • Kapp H.
        Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial.
        J Wound Care. 2005; 14: 320-323
        • Seaman S.
        Dressing selection in chronic wound management.
        J Am Podiatr Med Assoc. 2002; 92: 24-33
        • May S.R.
        An algorithm for wound management with natural and synthetic dressings.
        in: Krasner D. Chronic wound care: a clinical source book for healthcare professionals. Health Management Publications, Inc, King of Prussia, PA1990: 301-308
        • Bishop S.M.
        • Walker M.
        • Rogers A.A.
        • Chen W.Y.
        Importance of moisture balance at the wound-dressing interface.
        J Wound Care. 2003; 12: 125-128
        • Weigmann H.J.
        • Lindemann U.
        • Antoniou C.
        • Tsikrikas G.N.
        • Stratigos A.I.
        • Katsambas A.
        • et al.
        UV/VIS absorbance allows rapid, accurate, and reproducible mass determination of corneocytes removed by tape stripping.
        Skin Pharmacol Appl Skin Physiol. 2003; 16: 217-227
        • Cameron J.
        Exudate and care of the peri-wound skin.
        Nurs Stand. 2004; 19: 62-68
        • Cameron J.
        • Wilson C.
        • Powell S.
        • Cherry G.
        • Ryan T.
        Contact dermatitis in leg ulcer patients.
        Ostomy Wound Manage. 1992; 38: 8-11
        • Bolton L.
        • McNees P.
        • van Rijswijk L.
        • de Leon J.
        • Lyder C.
        • Kobza L.
        • et al.
        Wound-healing outcomes using standardized assessment and care in clinical practice.
        J Wound Ostomy Continence Nurs. 2004; 31: 65-71
        • Cho M.
        • Hunt T.K.
        The overall clinical approach to wounds.
        in: Falanga V. Cutaneous wound healing. Martin Dunitz, Ltd, London2001: 141-154
        • Kannon G.A.
        • Garrett A.B.
        Moist wound healing with occlusive dressings: a clinical review.
        Dermatol Surg. 1995; 21: 583-590
        • Baker P.D.
        Creating the optimal environment: an overview of dressings for chronic wounds.
        Adv Nurse Pract. 2005; 13: 37-38
        • Worley C.A.
        So, what do I put on this wound? The wound dressing puzzle: part III.
        Dermatol Nurs. 2005; 17: 299-300
        • Jones V.
        • Milton T.
        When and how to use hydrogels.
        Nurs Times. 2000; 96: 3-4
        • Lay-Flurrie K.
        The properties of hydrogel dressings and their impact on wound healing.
        Prof Nurse. 2004; 19: 269-273
        • Hampton S.
        A small study in healing rates and symptom control using a new sheet hydrogel dressing.
        J Wound Care. 2004; 13: 297-300
        • Hollinworth H.
        Pain relief.
        Nurs Times. 2001; 97: 63-66
        • Eisenbud D.
        • Hunter H.
        • Kessler L.
        • Zulkowski K.
        Hydrogel wound dressings: where do we stand in 2003?.
        Ostomy Wound Manage. 2003; 49: 52-57
        • Thomas S.
        • Hay P.
        Fluid handling properties of hydrogel dressings.
        Ostomy Wound Manage. 1995; 41: 54-59
        • Sprung P.
        • Hou Z.
        • Ladin D.A.
        Hydrogels and hydrocolloids: an objective product comparison.
        Ostomy Wound Manage. 1998; 44: 36-46
        • Bale S.
        • Banks V.
        • Haglestein S.
        • Harding K.G.
        A comparison of two amorphous hydrogels in the debridement of pressure sores.
        J Wound Care. 1998; 7: 65-68
        • Motta G.
        • Dunham L.
        • Dye T.
        • Mentz J.
        • O'Connell-Gifford E.
        • Smith E.
        Clinical efficacy and cost-effectiveness of a new synthetic polymer sheet wound dressing.
        Ostomy Wound Manage. 1999; 45: 41-49
        • Thomas D.R.
        • Goode P.S.
        • LaMaster K.
        • Tennyson T.
        Acemannan hydrogel dressing versus saline dressing for pressure ulcers: a randomized controlled trial.
        Adv Wound Care. 1998; 11: 273-276
        • Kaya A.Z.
        • Turani N.
        • Akyuz M.
        The effectiveness of a hydrogel dressing compared with standard management of pressure ulcers.
        J Wound Care. 2005; 14: 42-44
        • Szycher M.
        • Lee S.J.
        Modern wound dressings: a systematic approach to wound healing.
        J Biomater Appl. 1992; 7: 142-213
        • Ohura N.
        • Ichioka S.
        • Nakatsuka T.
        • Shibata M.
        Evaluating dressing materials for the prevention of shear force in the treatment of pressure ulcers.
        J Wound Care. 2005; 14: 401-404
        • Banks V.
        • Hagelstein S.
        • Thomas N.
        • Bale S.
        • Harding K.G.
        Comparing hydrocolloid dressings in management of exuding wounds.
        Br J Nurs. 1999; 8: 640-646
        • Bradley M.
        • Cullum N.
        • Nelson E.A.
        • Petticrew M.
        • Sheldon T.
        • Torgerson D.
        Systematic reviews of wound care management: (2) Dressings and topical agents used in the healing of chronic wounds.
        Health Technol Assess. 1999; 3: 1-137
        • Gorse G.J.
        • Messner R.L.
        Improved pressure sore healing with hydrocolloid dressings.
        Arch Dermatol. 1987; 123: 766-771
        • Fletcher J.
        Understanding wound dressings: alginates.
        Nurs Times. 2005; 101: 53-54
        • Taylor B.A.
        Selecting wound healing products: choices for long-term care settings.
        Adv Nurse Pract. 2003; 11: 63-66
        • Pirone L.A.
        • Bolton L.L.
        • Monte K.A.
        • Shannon R.J.
        Effect of calcium alginate dressings on partial-thickness wounds in swine.
        J Invest Surg. 1992; 5: 149-153
        • Segal H.C.
        • Hunt B.J.
        • Gilding K.
        The effects of alginate and non-alginate wound dressings on blood coagulation and platelet activation.
        J Biomater Appl. 1998; 12: 249-257
        • Barnett S.E.
        • Varley S.J.
        The effects of calcium alginate on wound healing.
        Ann R Coll Surg Engl. 1987; 69: 153-155
        • Agren M.S.
        Four alginate dressings in the treatment of partial thickness wounds: a comparative experimental study.
        Br J Plast Surg. 1996; 49: 129-134
        • Suzuki Y.
        • Tanihara M.
        • Nishimura Y.
        • Suzuki K.
        • Yamawaki Y.
        • Kudo H.
        • et al.
        In vivo evaluation of a novel alginate dressing.
        J Biomed Mater Res. 1999; 48: 522-527
        • Berry D.P.
        • Bale S.
        • Harding K.G.
        Dressings for treating cavity wounds.
        J Wound Care. 1996; 5: 10-17
        • Rosdy M.
        • Clauss L.C.
        Cytotoxicity testing of wound dressings using normal human keratinocytes in culture.
        J Biomed Mater Res. 1990; 24: 363-377
        • Doyle J.W.
        • Roth T.P.
        • Smith R.M.
        • Li Y.Q.
        • Dunn R.M.
        Effects of calcium alginate on cellular wound healing processes modeled in vitro.
        J Biomed Mater Res. 1996; 32: 561-568
        • Suzuki Y.
        • Nishimura Y.
        • Tanihara M.
        • Suzuki K.
        • Nakamura T.
        • Shimizu Y.
        • et al.
        Evaluation of a novel alginate gel dressing: cytotoxicity to fibroblasts in vitro and foreign-body reaction in pig skin in vivo.
        J Biomed Mater Res. 1998; 39: 317-322
        • Attwood A.I.
        Calcium alginate dressing accelerates split skin graft donor site healing.
        Br J Plast Surg. 1989; 42: 373-379
        • Sayag J.
        • Meaume S.
        • Bohbot S.
        Healing properties of calcium alginate dressings.
        J Wound Care. 1996; 5: 357-362
        • Lalau J.D.
        • Bresson R.
        • Charpentier P.
        • Coliche V.
        • Erlher S.
        • Ha Van G.
        • et al.
        Efficacy and tolerance of calcium alginate versus Vaseline gauze dressings in the treatment of diabetic foot lesions.
        Diabetes Metab. 2002; 28: 223-229
        • Limova M.
        Evaluation of two calcium alginate dressings in the management of venous ulcers.
        Ostomy Wound Manage. 2003; 49: 26-33
        • Fletcher J.
        Understanding wound dressings: foam dressings.
        Nurs Times. 2005; 101: 50-51
        • Rubin J.R.
        • Alexander J.
        • Plecha E.J.
        • Marman C.
        Unna's boot vs polyurethane foam dressings for the treatment of venous ulceration: a randomized prospective study.
        Arch Surg. 1990; 125: 489-490
        • Nisi G.
        • Brandi C.
        • Grimaldi L.
        • Calabro M.
        • D'Aniello C.
        Use of a protease-modulating matrix in the treatment of pressure sores.
        Chir Ital. 2005; 57: 465-468
        • Vin F.
        • Teot L.
        • Meaume S.
        The healing properties of Promogran in venous leg ulcers.
        J Wound Care. 2002; 11: 335-341
        • Cullen B.
        • Smith R.
        • McCulloch E.
        • Silcock D.
        • Morrison L.
        Mechanism of action of Promogran, a protease modulating matrix, for the treatment of diabetic foot ulcers.
        Wound Rep Reg. 2002; 10: 16-25
        • Barrett S.A.
        • Moore K.
        Use of Promogran to treat venous leg ulcers.
        J Wound Care. 2004; 13: S2-S7
        • Cullen B.
        • Watt P.W.
        • Lundqvist C.
        • Silcock D.
        • Schmidt R.J.
        • Bogan D.
        • et al.
        The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action.
        Int J Biochem Cell Biol. 2002; 34: 1544-1556
        • Mostow E.N.
        • Haraway G.D.
        • Dalsing M.
        • Hodde J.P.
        • King D.
        Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial.
        J Vasc Surg. 2005; 41: 837-843
        • Banta M.N.
        • Eaglstein W.H.
        • Kirsner R.S.
        Healing of refractory sinus tracts by dermal matrix injection with Cymetra.
        Dermatol Surg. 2003; 29: 863-866
        • Browne A.
        • Dow G.
        • Sibbald R.G.
        Infected wounds: definitions and controversies.
        in: Falanga V. Cutaneous wound healing. Martin Dunitz, Ltd, London2001: 203-220
        • Robson M.C.
        • Edstrom L.E.
        • Krizek T.J.
        • Groskin M.G.
        The efficacy of systemic antibiotics in the treatment of granulating wounds.
        J Surg Res. 1974; 16: 299-306
        • Heggers J.P.
        • Sazy J.A.
        • Stenberg B.D.
        • Strock L.L.
        • McCauley R.L.
        • Herndon D.N.
        • et al.
        Bactericidal and wound-healing properties of sodium-hypochlorite solutions.
        J Burn Care Rehabil. 1991; 12: 420-424
        • Ovington L.G.
        Battling bacteria in wound care.
        Home Healthc Nurse. 2001; 19: 622-631
        • Zhou L.H.
        • Nahm W.K.
        • Badiavas E.
        • Yufit T.
        • Falanga V.
        Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds.
        Br J Dermatol. 2002; 146: 365-374
        • Wright J.B.
        • Lam K.
        • Burrell R.E.
        Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment.
        Am J Infect Control. 1998; 26: 572-577
        • Strohal R.
        • Schelling M.
        • Takacs M.
        • Jurecka W.
        • Gruber U.
        • Offner F.
        Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new solution to an increasing problem.
        J Hosp Infect. 2005; 60: 226-230
        • Ip M.
        • Lui S.L.
        • Poon V.K.
        • Lung I.
        • Burd A.
        Antimicrobial activities of silver dressings: an in vitro comparison.
        J Med Microbiol. 2006; 55: 59-63
        • Lansdown A.B.
        Silver I: Its antibacterial properties and mechanism of action.
        J Wound Care. 2002; 11: 125-130
        • Modak S.M.
        • Fox C.L.
        Sulfadiazine silver-resistant Pseudomonas in burns: new topical agents.
        Arch Surg. 1981; 116: 854-857
        • Vermeulen H.
        • Ubbink D.T.
        • Storm-Versloot M.N.
        Topical silver for treating infected wounds.
        Cochrane Database Syst Rev. 2005; 4 (CD005486)
        • Thomas S.
        • McCubbin P.
        A comparison of the antimicrobial effects of four silver-containing dressings on three organisms.
        J Wound Care. 2003; 12: 101-107
        • Thomas S.
        • McCubbin P.
        An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings.
        J Wound Care. 2003; 12: 305-308
        • Greene R.M.
        • Su W.P.
        Argyria.
        Am Fam Physician. 1987; 36: 151-154
        • Lansdown A.B.
        • Williams A.
        How safe is silver in wound care?.
        J Wound Care. 2004; 13: 131-136
        • Hidalgo E.
        • Bartolome R.
        • Barroso C.
        • Moreno A.
        • Dominguez C.
        Silver nitrate: antimicrobial activity related to cytotoxicity in cultured human fibroblasts.
        Skin Pharmacol Appl Skin Physiol. 1998; 11: 140-151
        • Lam P.K.
        • Chan E.S.
        • Ho W.S.
        • Liew C.T.
        In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes.
        Br J Biomed Sci. 2004; 61: 125-127
        • Lansdown A.B.
        • Sampson B.
        • Laupattarakasem P.
        • Vuttivirojana A.
        Silver aids healing in the sterile skin wound: experimental studies in the laboratory rat.
        Br J Dermatol. 1997; 137: 728-735
        • Rojas A.I.
        • Phillips T.J.
        Venous ulcers and their management.
        in: Falanga V. Cutaneous wound healing. Martin Dunitz, Ltd, London2001: 263-286
        • Fletcher A.
        • Cullum N.
        • Sheldon T.A.
        A systematic review of compression treatment for venous leg ulcers.
        BMJ. 1997; 315: 576-580
        • Cullum N.
        • Nelson E.A.
        • Fletcher A.W.
        • Sheldon T.A.
        Compression bandages and stockings for venous leg ulcers.
        Cochrane Database Syst Rev. 2000; 2 (CD000265)
        • Falanga V.
        • Brem H.
        Wound bed preparation for optimal use of advanced therapeutic products.
        in: Falanga V. Cutaneous wound healing. Martin Dunitz Ltd, London2001: 457-468
        • Callam M.J.
        • Ruckley C.V.
        • Dale J.J.
        • Harper D.R.
        Hazards of compression treatment of the leg: an estimate from Scottish surgeons.
        Br Med J (Clin Res Ed). 1987; 295: 1382
        • Stromberg H.E.
        • Agren M.S.
        Topical zinc oxide treatment improves arterial and venous leg ulcers.
        Br J Dermatol. 1984; 111: 461-468
        • Agren M.S.
        • Chvapil M.
        • Franzen L.
        Enhancement of re-epithelialization with topical zinc oxide in porcine partial-thickness wounds.
        J Surg Res. 1991; 50: 101-105
        • Coutts P.
        • Queen D.
        • Sibbald R.G.
        Peri-wound skin protection: a comparison of a new skin barrier vs. traditional therapies in wound management. Canadian Association of Wound Care.
        (Available at:) (Accessed August 5, 2006)
        • Hess C.L.
        • Howard M.A.
        • Attinger C.E.
        A review of mechanical adjuncts in wound healing: hydrotherapy, ultrasound, negative pressure therapy, hyperbaric oxygen, and electrostimulation.
        Ann Plast Surg. 2003; 51: 210-218
        • Morykwas M.J.
        • Argenta L.C.
        • Shelton-Brown E.L.
        • McGuirt W.
        Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation.
        Ann Plast Surg. 1997; 38: 553-562
        • Saxena V.
        • Hwang C.W.
        • Huang S.
        • Eichbaum Q.
        • Ingber D.
        • Orgill D.P.
        Vacuum-assisted closure: microdeformations of wounds and cell proliferation.
        Plast Reconstr Surg. 2004; 114: 1086-1098
        • Shirakawa M.
        • Isseroff R.R.
        Topical negative pressure devices: use for enhancement of healing chronic wounds.
        Arch Dermatol. 2005; 141: 1449-1453
        • Venturi M.L.
        • Attinger C.E.
        • Mesbahi A.N.
        • Hess C.L.
        • Graw K.S.
        Mechanisms and clinical applications of the vacuum-assisted closure (VAC) device: a review.
        Am J Clin Dermatol. 2005; 6: 185-194
        • Clare M.P.
        • Fitzgibbons T.C.
        • McMullen S.T.
        • Stice R.C.
        • Hayes D.F.
        • Henkel L.
        Experience with the vacuum assisted closure negative pressure technique in the treatment of non-healing diabetic and dysvascular wounds.
        Foot Ankle Int. 2002; 23: 896-901
        • Banwell P.E.
        • Teot L.
        Topical negative pressure (TNP): the evolution of a novel wound therapy.
        J Wound Care. 2003; 12: 22-28
        • Evans D.
        • Land L.
        Topical negative pressure for treating chronic wounds.
        Cochrane Database Syst Rev. 2001; 1 (CD001898)
        • Robson M.C.
        • Smith P.D.
        Topical use of growth factors to enhance healing.
        in: Falanga V. Cutaneous wound healing. Martin Dunitz, Ltd, London2001: 379-398
        • Pierce G.F.
        • Mustoe T.A.
        • Altrock B.W.
        • Deuel T.F.
        • Thomason A.
        Role of platelet-derived growth factor in wound healing.
        J Cell Biochem. 1991; 45: 319-326
        • Steed D.L.
        Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group.
        J Vasc Surg. 1995; 21: 71-78
        • Ladin D.
        Becaplermin gel (PDGF-BB) as topical wound therapy. Plastic Surgery Educational Foundation DATA Committee.
        Plast Reconstr Surg. 2000; 105: 1230-1231
        • Robson M.C.
        • Phillips L.G.
        • Thomason A.
        • Robson L.E.
        • Pierce G.F.
        Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.
        Lancet. 1992; 339: 23-25
        • Mustoe T.A.
        • Cutler N.R.
        • Allman R.M.
        • Goode P.S.
        • Deuel T.F.
        • Prause J.A.
        • et al.
        A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers.
        Arch Surg. 1994; 129: 213-219
        • Rees R.S.
        • Robson M.C.
        • Smiell J.M.
        • Perry B.H.
        Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study.
        Wound Repair Regen. 1999; 7: 141-147
        • Gentzkow G.D.
        • Iwasaki S.D.
        • Hershon K.S.
        • Mengel M.
        • Prendergast J.J.
        • Ricotta J.J.
        • et al.
        Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers.
        Diabetes Care. 1996; 19: 350-354
        • Falanga V.
        • Sabolinski M.
        A bilayered living skin construct (Apligraf) accelerates complete closure of hard-to-heal venous ulcers.
        Wound Repair Regen. 1999; 7: 201-207
        • Veves A.
        • Falanga V.
        • Armstrong D.G.
        • Sabolinski M.L.
        Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.
        Diabetes Care. 2001; 24: 290-295
        • Jones I.
        • Currie L.
        • Martin R.
        A guide to biological skin substitutes.
        Br J Plast Surg. 2002; 55: 185-193
        • Marston W.A.
        • Hanft J.
        • Norwood P.
        • Pollak R.
        The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.
        Diabetes Care. 2003; 26: 1701-1705
        • Omar A.A.
        • Mavor A.I.
        • Jones A.M.
        • Homer-Vanniasinkam S.
        Treatment of venous leg ulcers with Dermagraft.
        Eur J Endovasc Surg. 2004; 27: 666-672
        • Kranke P.
        • Bennett M.
        • Roeckl-Wiedmann I.
        • Debus S.
        Hyperbaric oxygen therapy for chronic wounds.
        Cochrane Database Syst Rev. 2004; 1 (CD004123)
        • Berendt A.R.
        Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective.
        Clin Infect Dis. 2006; 43: 193-198
        • Cronje F.J.
        Oxygen therapy and wound healing—topical oxygen is not hyberbaric oxygen therapy.
        S Afr Med J. 2005; 95: 840
        • Paquette D.
        • Badiavas E.
        • Falanga V.
        Short-contact topical tretinoin therapy to stimulate granulation tissue in chronic wounds.
        J Am Acad Dermatol. 2001; 45: 382-386
        • Tom W.L.
        • Peng D.H.
        • Allaei A.
        • Hsu D.
        • Hata T.R.
        The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes.
        Arch Dermatol. 2005; 141: 1373-1377
        • Jull A.B.
        • Waters J.
        • Arroll B.
        Pentoxifylline for treating venous leg ulcers.
        Cochrane Database Syst Rev. 2002; 1 (CD001733)
        • Jarret P.E.
        • Moreland M.
        • Browse N.L.
        The effect of oxpentifylline (“Trental”) on fibrinolytic activity and plasma fibrinogen levels.
        Curr Med Res Opin. 1977; 4: 492-495
        • Schroer R.H.
        Antithrombotic potential of pentoxifylline: a hemorheologically active drug.
        Angiology. 1985; 36: 387-398
        • Ambrus J.L.
        • Ambrus C.M.
        • Mahfzah M.
        • Markus J.A.
        • Klein E.
        • Gastpar H.
        Mechanism of the potentiation of thrombolysis by pentoxifylline (Trental).
        J Med. 1987; 18: 265-276
        • Zabel P.
        • Schade F.U.
        • Schlaak M.
        Inhibition of endogenous TNF formation by pentoxifylline.
        Immunobiology. 1993; 187: 447-463
        • Falanga V.
        • Fujitani R.M.
        • Diaz C.
        • Hunter G.
        • Jorizzo J.
        • Lawrence P.F.
        • et al.
        Systematic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo-controlled trial.
        Wound Repair Regen. 1999; 7: 208-213
        • Piacquadio D.
        • Nelson D.B.
        Alginates: a “new” dressing alternative.
        J Dermatol Surg Oncol. 1992; 18: 992-995
        • Cameron J.
        • Hoffman D.
        • Wilson J.
        • Cherry G.
        Comparison of two peri-wound skin protectants in venous leg ulcers: a randomised controlled trial.
        J Wound Care. 2005; 14: 233-236
      1. Edgepark Surgical 2005 Catalog. Twinsburg, Ohio.

      2. Prices available at: www.drugstore.com. Accessed August 8, 2006.

        • Frankel V.H.
        • Serafica G.C.
        • Damien C.J.
        Development and testing of a novel biosynthesized XCell for treating chronic wounds.
        Surg Technol Int. 2004; 12: 27-33
        • Vuolo J.
        Current options for managing the problem of excess wound exudate.
        Prof Nurse. 2004; 19: 487-491
        • Robinson B.J.
        The use of a hydrofibre dressing in wound management.
        J Wound Care. 2000; 9: 32-34
        • Holloway G.A.
        • Johansen K.H.
        • Barnes R.W.
        • Pierce G.E.
        Multicenter trial of cadexomer iodine to treat venous stasis ulcer.
        West J Med. 1989; 151: 35-38
        • Skog E.
        • Arnesjo B.
        • Troeng T.
        • Gjores J.E.
        • Bergljung L.
        • Gundersen J.
        • et al.
        A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers.
        Br J Dermatol. 1983; 109: 77-83
        • Moberg S.
        • Hoffman L.
        • Grennert M.L.
        • Holst A.
        A randomized trial of cadexomer iodine in decubitus ulcers.
        J Am Geriatr Soc. 1983; 31: 462-465
        • Hoekstra M.J.
        • Hupkens P.
        • Dutrieux R.P.
        • Bosch M.M.
        • Brans T.A.
        • Kreis R.W.
        A comparative burn wound model in the New Yorkshire pig for the histopathological evaluation of local therapeutic regimens: silver sulfadiazine cream as a standard.
        Br J Plast Surg. 1993; 46: 585-589
        • Lansdown A.B.
        • Jensen K.
        • Jensen M.Q.
        Contreet Foam and Contreet Hydrocolloid: an insight into two new silver-containing dressings.
        J Wound Care. 2003; 12: 205-210

      Linked Article